New innovation in digital PCR - Opal Chips

Stilla Technologies provides a full solution for the analysis of genetics testing using Crystal Digital PCR™ on the naica® system. Our latest innovation, the Opal chip is a higher throughput digital PCR consumable that enables the generation of up to 20.000 droplets/sample and up to 16 samples/chip. All of our consumables, the Sapphire & the Opal chip are fully compatible with our naica® PCR MIX reagents: the naica® PCR MIX & naica® multiplex PCR MIX on the naica® system.

Don't miss to install the NEW Crystal Reader & Crystal Miner software update of the naica® system to benefit from the full potential of Crystal Digital PCR™.

For more info on the Opal chip, download the brochure here: https://lnkd.in/dbJXBc4

Discover the naica® system workflow here: https://lnkd.in/dNGqQPG

Request a quote now at sales@stilla.fr

Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a ground-breaking and flexible digital PCR (dPCR) solution: the naica® system. Taking advantage of cutting-edge microfluidic innovations, Stilla® aims to make dPCR a lab commodity in all Life Sciences areas: research, therapeutics, and all the “omics”.  At Stilla Technologies, we continuously innovate and evolve technologically toward better human health outcomes. Our global team with multidisciplinary expertise shares a passion to develop new products for advanced genetic testing and analysis. Our expertise spans from microfluidics and chemistry to molecular biology and computer science. Our product, the naica® System, has been adopted by researchers & clinicians around the world to develop a wide range of genetic tests and molecular biology assays – including, but not limited to, liquid biopsy tests for cancer diagnostics, infectious diseases, prenatal testing, and GMO detection.

https://www.stillatechnologies.com/

#digitalPCR #dPCR #genetic #innovation